| 1 |
34954721 | Lipidomics in diabetes. | 2022 Apr 1 |
1 |
| 2 |
34962430 | Insulin regulates Nedd4-2 via a PKB-dependent mechanism in HEI-OC1 auditory cells-crosstalks with sphingolipid and cAMP signaling. | 2022 Jan |
1 |
| 3 |
35054078 | Serum C18:1-Cer as a Potential Biomarker for Early Detection of Gestational Diabetes. | 2022 Jan 13 |
1 |
| 4 |
35406045 | Effects of Isocaloric Fructose Restriction on Ceramide Levels in Children with Obesity and Cardiometabolic Risk: Relation to Hepatic De Novo Lipogenesis and Insulin Sensitivity. | 2022 Mar 30 |
1 |
| 5 |
35584813 | The Lard Works in Mysterious Ways: Ceramides in Nutrition-Linked Chronic Disease. | 2022 May 18 |
1 |
| 6 |
33128577 | Subcellular localisation and composition of intramuscular triacylglycerol influence insulin sensitivity in humans. | 2021 Jan |
1 |
| 7 |
33158378 | Ceramides in Metabolism: Key Lipotoxic Players. | 2021 Feb 10 |
1 |
| 8 |
33504931 | A prospective study of maternal adiposity and glycemic traits across pregnancy and mid-childhood metabolomic profiles. | 2021 Apr |
1 |
| 9 |
33592213 | Targeted lipidomics reveals associations between serum sphingolipids and insulin sensitivity measured by the hyperinsulinemic-euglycemic clamp. | 2021 Mar |
4 |
| 10 |
33738905 | Neutral sphingomyelinase-2 and cardiometabolic diseases. | 2021 Aug |
1 |
| 11 |
33815291 | Sphingolipids as a Culprit of Mitochondrial Dysfunction in Insulin Resistance and Type 2 Diabetes. | 2021 |
4 |
| 12 |
34204938 | Vitamin K2 as a New Modulator of the Ceramide De Novo Synthesis Pathway. | 2021 Jun 3 |
3 |
| 13 |
32098447 | Influence of Exercise Training on Skeletal Muscle Insulin Resistance in Aging: Spotlight on Muscle Ceramides. | 2020 Feb 22 |
1 |
| 14 |
32424203 | Sphingolipids produced by gut bacteria enter host metabolic pathways impacting ceramide levels. | 2020 May 18 |
2 |
| 15 |
33296380 | Associations among circulating sphingolipids, β-cell function, and risk of developing type 2 diabetes: A population-based cohort study in China. | 2020 Dec |
1 |
| 16 |
30468835 | The effect of enterolactone on sphingolipid pathway and hepatic insulin resistance development in HepG2 cells. | 2019 Jan 15 |
1 |
| 17 |
30586632 | Lipidomic profiling reveals early-stage metabolic dysfunction in overweight or obese humans. | 2019 Mar |
2 |
| 18 |
30594552 | Circulating sphingolipids, fasting glucose, and impaired fasting glucose: The Strong Heart Family Study. | 2019 Mar |
1 |
| 19 |
30630661 | Analysis of sphingolipid composition in human vitreous from control and diabetic individuals. | 2019 Mar |
1 |
| 20 |
30645667 | The discovery of novel predictive biomarkers and early-stage pathophysiology for the transition from gestational diabetes to type 2 diabetes. | 2019 Apr |
1 |
| 21 |
31150623 | CerS6-Derived Sphingolipids Interact with Mff and Promote Mitochondrial Fragmentation in Obesity. | 2019 May 30 |
1 |
| 22 |
31545927 | Lipid mediators of insulin signaling in diabetic kidney disease. | 2019 Nov 1 |
1 |
| 23 |
29415895 | Intracellular localization of diacylglycerols and sphingolipids influences insulin sensitivity and mitochondrial function in human skeletal muscle. | 2018 Feb 8 |
2 |
| 24 |
29485983 | Beyond fitness tracking: The use of consumer-grade wearable data from normal volunteers in cardiovascular and lipidomics research. | 2018 Feb |
1 |
| 25 |
29588286 | Circulating Sphingolipids, Insulin, HOMA-IR, and HOMA-B: The Strong Heart Family Study. | 2018 Aug |
3 |
| 26 |
29602794 | Specific Hepatic Sphingolipids Relate to Insulin Resistance, Oxidative Stress, and Inflammation in Nonalcoholic Steatohepatitis. | 2018 Jun |
2 |
| 27 |
29767564 | Interorgan Metabolic Crosstalk in Human Insulin Resistance. | 2018 Jul 1 |
1 |
| 28 |
30159588 | Relation of plasma ceramides to visceral adiposity, insulin resistance and the development of type 2 diabetes mellitus: the Dallas Heart Study. | 2018 Dec |
1 |
| 29 |
30473005 | Sphingolipids in adipose tissue: What's tipping the scale? | 2018 Dec |
1 |
| 30 |
27940403 | Markers of sympathetic nervous system activity associate with complex plasma lipids in metabolic syndrome subjects. | 2017 Jan |
2 |
| 31 |
28462811 | Sphingolipids and Lipoproteins in Health and Metabolic Disorders. | 2017 Jul |
1 |
| 32 |
28714882 | Vitamin D Supplementation Enhances C18(dihydro)ceramide Levels in Type 2 Diabetes Patients. | 2017 Jul 15 |
1 |
| 33 |
29186855 | Translational Aspects of Sphingolipid Metabolism in Renal Disorders. | 2017 Nov 25 |
1 |
| 34 |
26739815 | Muscle sphingolipids during rest and exercise: a C18:0 signature for insulin resistance in humans. | 2016 Apr |
3 |
| 35 |
26916476 | Skeletal muscle and plasma lipidomic signatures of insulin resistance and overweight/obesity in humans. | 2016 Apr |
3 |
| 36 |
25623782 | Elevation of plasma 1-deoxy-sphingolipids in type 2 diabetes mellitus: a susceptibility to neuropathy? | 2015 May |
1 |
| 37 |
26126684 | Serum sphingolipids: relationships to insulin sensitivity and changes with exercise in humans. | 2015 Aug 15 |
2 |
| 38 |
26350457 | Microsomal Triglyceride Transfer Protein Transfers and Determines Plasma Concentrations of Ceramide and Sphingomyelin but Not Glycosylceramide. | 2015 Oct 23 |
1 |
| 39 |
26380311 | Inhibition of Ceramide De Novo Synthesis Ameliorates Diet Induced Skeletal Muscles Insulin Resistance. | 2015 |
1 |
| 40 |
26412155 | Ceramides - Lipotoxic Inducers of Metabolic Disorders. | 2015 Oct |
1 |
| 41 |
24214972 | Ceramides and glucosylceramides are independent antagonists of insulin signaling. | 2014 Jan 10 |
1 |
| 42 |
24379346 | Deoxysphingolipids, novel biomarkers for type 2 diabetes, are cytotoxic for insulin-producing cells. | 2014 Apr |
1 |
| 43 |
24749054 | On ceramides, other sphingolipids and impaired glucose homeostasis. | 2014 Jun |
1 |
| 44 |
25295789 | CerS2 haploinsufficiency inhibits β-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance. | 2014 Oct 7 |
1 |
| 45 |
25305670 | Altered sphingoid base profiles in type 1 compared to type 2 diabetes. | 2014 Oct 11 |
1 |
| 46 |
25329603 | Altered levels of serum sphingomyelin and ceramide containing distinct acyl chains in young obese adults. | 2014 Oct 20 |
1 |
| 47 |
29643939 | Sphingolipid regulators of cellular dysfunction in Type 2 diabetes mellitus: a systems overview. | 2014 |
1 |
| 48 |
23250746 | Palmitate and lipopolysaccharide trigger synergistic ceramide production in primary macrophages. | 2013 Feb 1 |
1 |
| 49 |
23563667 | Sphingolipids in obesity, type 2 diabetes, and metabolic disease. | 2013 |
2 |
| 50 |
23857140 | Development and validation of LC-MS/MS method for determination of very long acyl chain (C22:0 and C24:0) ceramides in human plasma. | 2013 Sep |
1 |